FindTrial
Sign In

Screening early warning markers for gestational diabetes mellitus

Study on screening early warning markers for gestational diabetes mellitus using eccDNA high-throughput gene sequencing technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095240
Enrollment
Unknown
Registered
2025-01-03
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

GDM group:none
Control group:none

Sponsors

Jinan Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women at 11-13+6 weeks of gestation; 2. Pregnant women planning regular antenatal examinations at this institution.

Exclusion criteria

Exclusion criteria: 1) Previously diagnosed with diabetes; 2) Pregnant with twins or multiple pregnancies; 3) Severe acute or chronic diseases, such as severe liver dysfunction, renal dysfunction, thyroid dysfunction, cardiovascular and cerebrovascular diseases, pneumonia, pulmonary tuberculosis, respiratory system diseases, systemic lupus erythematosus, rheumatoid arthritis, autoimmune diseases, blood system or tumor-related diseases, etc. 4) The subject or their family members are unable to understand or cooperate with the study.

Design outcomes

Primary

MeasureTime frame
eccDNA;—

Countries

China

Contacts

Public ContactJin Wang

Jinan Maternal and Child Health Care Hospital

wangjinsmu@163.com+86 531 89029793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026